Cipla Ltd maintains a strong liquidity position, with a current ratio of 3.71, indicating the company can easily cover its short-term liabilities with its short-term assets. The company's liquidity…
Envoy Medical Inc operates with a negative equity position of $12.16 million and a total asset base of $8.56 million, indicating a highly leveraged and capital-intensive structure. The company's li…
CRSP.O has a highly liquid capital structure, with a current ratio of 13.32, indicating strong short-term liquidity. The company is entirely equity-funded, with no long-term debt, and a debt-to-equ…
Citius Oncology Inc has a market capitalization of $86.89 million and a price-to-book ratio of 1.94, indicating that the market values the company at a premium to its book value. The company's liqu…
Structure and Liquidity Johnson & Johnson maintains a debt-to-equity ratio of 0.58, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, wi…
Eledon Pharmaceuticals Inc has a negative net income of $44.91 million and a negative total equity of $8.50 million, indicating a significant financial challenge. The company's liquidity position i…
Evolus operates with a negative equity position of -$23.1 million and a total debt of $146.1 million, resulting in a debt-to-equity ratio of -6.32. The company holds $53.8 million in cash and equiv…
Fortis Healthcare Ltd maintains a debt-to-equity ratio of 0.28, indicating a relatively conservative capital structure. The company's liquidity position is characterized as medium, with a current r…
Galectin Therapeutics Inc operates with a negative equity position of -$71.09 million and a total liability of $96.98 million, indicating a levered capital structure. The company's liquidity positi…
Hyperion DeFi Inc has a market capitalization of $51.43 million and a price-to-book ratio of 28.29, indicating a significant premium to its book value. The company's liquidity position is character…
The company maintains a strong liquidity position, with a current ratio of 5.7 and $9.3 million in cash and equivalents, which is significantly higher than the typical liquidity requirements for a…
Kotra Industries Bhd maintains a strong liquidity position, with a current ratio of 2.9, indicating the company can cover its short-term liabilities more than two times over. However, the company r…
Keros Therapeutics maintains a strong liquidity position, with cash and equivalents amounting to $287.4 million, representing 85% of total assets. The company has no long-term debt and a current ra…
Korro Bio Inc has a market capitalization of $161.53 million and a price-to-book ratio of 3.14, indicating a premium valuation relative to its book value. The company holds $21.82 million in cash a…
MKDWELL Tech Inc has a strong liquidity position, with a current ratio of 2.32, indicating the company can cover its short-term obligations with its current assets. The company has no long-term deb…
Pulmonx operates with a market capitalization of $56.6 million and a price-to-book ratio of 1.05, indicating a valuation closely aligned with its tangible book value. The company's liquidity positi…
Veradigm's capital structure is supported by a strong liquidity position, with $446.6 million in cash and equivalents, representing 29.7% of total assets. The company maintains a conservative debt-…
Structure and Liquidity Metagenomi Therapeutics Inc has a market capitalization of $50.8 million and a price-to-book ratio of 0.32, indicating a significant discount to its book value. The company…
Niagen Bioscience Inc maintains a strong liquidity position, with a current ratio of 4.86, indicating the company has nearly five times more current assets than current liabilities. The company has…
The company maintains a strong liquidity position, with a current ratio of 19.69, indicating a high ability to meet short-term obligations. It has no long-term debt and holds $24.89 million in cash…
Neogen Corp exhibits a capital structure with a debt-to-equity ratio of 0.43, indicating a moderate reliance on debt financing. The company holds $129.0 million in cash and equivalents, but its lon…
Nephrocare's capital structure is relatively conservative, with a debt-to-equity ratio of 0.44, indicating a balanced approach to financing. The company maintains a current ratio of 1.92, suggestin…
Minerva Neurosciences Inc has a negative equity position of -$44.49 million and a total debt of $86.58 million, indicating a leveraged capital structure. The company's liquidity is supported by $30…
NIOX.L maintains a strong liquidity position, with a current ratio of 3.81, indicating the company can cover its short-term liabilities more than three times over. The company's liquidity_fpt score…
Nurix Therapeutics Inc has a market capitalization of $1.81 billion and a price-to-book ratio of 3.37, indicating a premium valuation relative to its book value. The company holds $246.96 million i…
Oramed Pharmaceuticals Inc has a market capitalization of $191.31 million and a price-to-earnings ratio of 124.55, indicating a high valuation relative to its earnings. The company's liquidity posi…
Oryzon Genomics has a liquidity position characterized by a current ratio of 1.95, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's fre…
Phathom Pharmaceuticals Inc operates with a capital structure that reflects significant leverage and negative equity. The company's total liabilities exceed total assets by $438.17 million, resulti…
Phio Pharmaceuticals Corp maintains a strong liquidity position, with a current ratio of 3.47 and cash and equivalents of $4.698 million, which significantly exceeds its total liabilities of $1.523…
ProMIS Neurosciences Inc operates with a highly leveraged equity structure, as evidenced by a price-to-book ratio of 1230.59 and a price-to-tangible-book ratio of 1230.59, indicating that the marke…
The company maintains a strong liquidity position with $48.5 million in cash and equivalents, representing 20.4% of total assets, and a current ratio of 19.22, significantly above the industry medi…
Privia Health Group Inc maintains a strong liquidity position, with $479.69 million in cash and equivalents, representing 35% of total assets. The company has no long-term debt and a current ratio…
Q & M Dental Group (Singapore) Ltd maintains a liquidity position with a current ratio of 4.75, indicating strong short-term liquidity. However, the company's debt-to-equity ratio of 1.81 suggests…
Rani Therapeutics operates with a capital structure that is entirely equity-funded, as it has no long-term debt and a debt-to-equity ratio of 0.0. The company maintains a strong liquidity position,…
Laboratorio Reig Jofre SA maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.42, indicating a moderate reliance on debt financing. The company's liquidity posit…
Rockwell Medical maintains a conservative capital structure with $11.86 million in cash and equivalents, representing 22.4% of total assets, and a current ratio of 2.0. The company's liquidity posi…
RenovoRx operates with a strong liquidity position, as evidenced by $4.39 million in cash and equivalents, which significantly exceeds its total liabilities of $3.02 million, resulting in a current…
ROVI's capital structure is characterized by a debt-to-equity ratio of 0.18, indicating a relatively low leverage position compared to the industry median of 0.35. The company's liquidity is assess…
Sangamo Therapeutics operates with a negative equity position of -$14.27 million and a market capitalization of $49.38 million, indicating a highly leveraged and capital-intensive business model. T…
Shalby Ltd's capital structure is characterized by a debt-to-equity ratio of 0.48, indicating a relatively conservative leverage position compared to the industry median. The company's liquidity is…
SI-BONE Inc operates with a market capitalization of $655.25 million and a price-to-book ratio of 3.69, indicating a premium valuation relative to its book value. The company holds $42.24 million i…
SinterCast operates with a highly liquid capital structure, as evidenced by a current ratio of 4.7, indicating strong short-term liquidity. The company's total liabilities are relatively low at 10.…
SONA.CD has a negative equity position of -38,780 CAD, indicating a significant financial challenge, and a debt-to-equity ratio of -7.94, which suggests a high reliance on debt financing. The compa…
Stille AB maintains a conservative capital structure with a debt-to-equity ratio of 0.15, indicating a low reliance on debt financing. The company's liquidity position is characterized by a current…
SynAct Pharma has a strong liquidity position, with a current ratio of 2.31 and cash and equivalents amounting to 51.55 million SEK, which is a significant portion of its total assets of 213.35 mil…
UMedic Group Bhd maintains a strong liquidity position, with a current ratio of 9.48, indicating that the company has significantly more current assets than current liabilities. The company's liqui…
DENTSPLY SIRONA Inc operates with a debt-to-equity ratio of 1.74, indicating a relatively high leverage position compared to industry norms. The company's liquidity is assessed as medium, with a cu…
Zentalis Pharmaceuticals Inc operates with a market capitalization of $291.15 million and a price-to-book ratio of 0.76, indicating that the company is trading at a discount to its book value. The…
Boryung Corp maintains a relatively strong liquidity position, with a current ratio of 1.7, indicating the company can cover its short-term liabilities with its short-term assets. However, the comp…
Jacobio Pharmaceuticals Group Co Ltd maintains a strong liquidity position, with a current ratio of 5.1, indicating that it has more than five times the current assets to cover its current liabilit…
iMarketKorea Inc maintains a strong liquidity position, with cash and equivalents amounting to KRW 719.32 million, and a current ratio of 1.57, indicating the company can cover its short-term liabi…
LigaChem Biosciences Inc has a strong liquidity position, with a current ratio of 8.54, indicating that the company holds significantly more current assets than current liabilities. The company mai…
Ping An Healthcare and Technology Co Ltd maintains a strong liquidity position, with a current ratio of 2.7 and cash and equivalents of CNY 1.23 billion. The company's debt-to-equity ratio is 0.01,…
The company's capital structure is characterized by a debt-to-equity ratio of 0.47, indicating a relatively conservative leverage position. With cash and equivalents amounting to 503,066,000 CNY, t…
Yidu Tech Inc operates with a capital structure that is predominantly equity-funded, with total equity of CNY 3.92 billion and total liabilities of CNY 767.8 million, resulting in a low debt-to-equ…
The company maintains a conservative capital structure, with a debt-to-equity ratio of 0.32, indicating a relatively low reliance on debt financing. Its liquidity position is characterized as mediu…
Betta Pharmaceuticals has a total equity of CNY 6.595 billion and total liabilities of CNY 3.97 billion, resulting in a debt-to-equity ratio of 0.38, which is relatively low compared to the industr…
Pharmaron Beijing maintains a conservative capital structure with a debt-to-equity ratio of 0.65, indicating a balanced approach to leverage. The company holds CNY 4.57 billion in cash and equivale…
Pacific Hospital Supply Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.14, significantly below the industry median of 0.45, indicating a low reliance on debt fin…
Kyorin Pharmaceutical maintains a conservative capital structure, with a debt-to-equity ratio of 0.21 and a current ratio of 3.88, indicating strong short-term liquidity. The company's liquidity po…
Medipal Holdings Corp maintains a strong liquidity position, with cash and equivalents amounting to ¥261.4 billion, representing 14.3% of total assets. The company's liquidity FPT score of 0.91 ind…
Acrivon Therapeutics Inc has a market capitalization of $82.18 million and a price-to-book ratio of 0.73, indicating that the company is trading at a discount to its book value. The company's liqui…
ALEC Holdings PJSC maintains a leveraged capital structure with total liabilities of 9.23 billion AED against total equity of 1.39 billion AED, resulting in a debt-to-equity ratio of 0.67. The comp…
ANCR.L has a debt-to-equity ratio of 0.2 and a current ratio of 4.75, indicating a strong liquidity position with ample short-term assets to cover liabilities. The company's free cash flow of 5.97…
Actinium Pharmaceuticals Inc has a strong liquidity position, with cash and equivalents amounting to $86.0 million, which is significantly higher than its total liabilities of $46.0 million, result…
Biodesix operates with a capital structure that includes $35.84 million in long-term debt and $42.22 million in cash and equivalents, resulting in a debt-to-equity ratio of 0.99 and a current ratio…
Biomea Fusion Inc maintains a strong liquidity position, with $113.29 million in cash and equivalents, representing 83.2% of its total assets. The company has no long-term debt and a current ratio…
C4 Therapeutics maintains a strong liquidity position with a current ratio of 7.81 and holds $74.6 million in cash and equivalents, indicating a robust short-term financial buffer. The company has…
Corline Biomedical maintains a strong liquidity position with a current ratio of 2.42 and cash and equivalents of 17.47 million SEK, indicating the company is well-positioned to meet short-term obl…
Centessa Pharmaceuticals maintains a capital structure characterized by significant equity relative to liabilities, with total equity of $526.9 million against total liabilities of $160.6 million.…
China Pharma Holdings, Inc. manufactures and sells generic drugs and modern Traditional Chinese Medicines in the People's Republic of China, generating revenue through an academic-driven promotion…
Citius Pharmaceuticals Inc has a market capitalization of $19.52 million and a price-to-book ratio of 0.23, indicating a significant discount to its book value. The company's liquidity position is…
CVS Health Corp maintains a debt-to-equity ratio of 0.86, indicating a relatively balanced capital structure, while its current ratio of 0.84 suggests moderate liquidity risk. The company's free ca…
Cyclerion Therapeutics Inc maintains a strong liquidity position, with a current ratio of 5.15 and $3.24 million in cash and equivalents, indicating a solid short-term financial buffer. The company…
The company maintains a strong liquidity position, with a current ratio of 6.63 and cash and equivalents of $11.06 million, indicating a robust ability to meet short-term obligations. The debt-to-e…
Glucotrack, Inc. develops the Glucotrack CBGM, a non-invasive continuous blood glucose monitoring device, but has not yet commercialized the product or generated revenue. The company operates in th…
Haleon Pakistan Ltd maintains a strong liquidity position, with a current ratio of 1.36, indicating the company can cover its short-term liabilities with its short-term assets. The company's liquid…
IGC Pharma, Inc. is a pharmaceutical company that generates revenue from the development and sale of pharmaceutical products, currently operating at a significant net loss while relying on equity i…
Mink Therapeutics Inc operates with a negative equity position of -$14.23 million and a cash and equivalents balance of $13.36 million, indicating a liquidity position that is just sufficient to co…
Izotropic Corp has a highly leveraged capital structure, with total liabilities of CAD 4,078,630 and total equity of CAD -3,846,250, resulting in a negative net worth. The company's liquidity posit…
Karyopharm Therapeutics Inc operates with a negative equity position of -$292.93 million and a total liabilities of $401.34 million, indicating a levered capital structure with a debt-to-equity rat…
Kura Oncology Inc has a market capitalization of $987.93 million and a price-to-book ratio of 5.67, indicating a premium valuation relative to its book value. The company holds $149.10 million in c…
Kyntra Bio Inc operates with a negative equity position of $228.12 million and a cash and equivalents balance of $68.57 million, indicating a liquidity position that is constrained by its $89.66 mi…
Longeveron operates with a highly leveraged capital structure, as evidenced by its price-to-book ratio of 4.45 and a price-to-tangible-book ratio of 4.45, indicating that the market values the comp…
LINP.NS maintains a strong liquidity position, with a current ratio of 4.71, indicating that the company has sufficient current assets to cover its current liabilities multiple times over. The comp…
LENSAR operates with a negative equity position of -$12.24 million and a cash balance of $12.97 million, indicating a liquidity risk despite the absence of long-term debt. The company's market capi…
Liquidia Corp has a high price-to-book ratio of 123.11, indicating that the market is valuing the company significantly above its book value. The company's liquidity position is characterized by a…
The company maintains a relatively strong liquidity position, with NGN 4.13 billion in cash and equivalents, but its long-term debt of NGN 6.32 billion exceeds its cash reserves, resulting in a net…
MODUL.HE's capital structure is characterized by a strong liquidity position, with EUR 9.65 million in cash and equivalents, and a current ratio of 4.46, indicating a robust ability to meet short-t…
MaxCyte operates with a strong liquidity position, as evidenced by a current ratio of 8.3 and cash and equivalents of $20.07 million. The company has no long-term debt, and its debt-to-equity ratio…
Myriad Genetics operates with a market capitalization of $369.27 million and a price-to-book ratio of 1.0, indicating that the market values the company at par with its book value. The company hold…
New Hope Corporation Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.14 and a current ratio of 2.08, indicating strong short-term liquidity coverage. The company hol…
NeuPath Health Inc operates with a debt-to-equity ratio of 0.55, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.13, sugg…
Oragenics Inc. is a clinical-stage biopharmaceutical company developing novel therapies for cancer and other diseases, relying on external financing to fund research and development activities in t…
Onconetix, Inc. is a pharmaceutical company that develops and commercializes diagnostic products, specifically Proclarix, relying on third-party partners like Laboratory Corporation of America for…
ONWARD Medical's capital structure is characterized by a strong liquidity position, with EUR 59.06 million in cash and equivalents, representing 69.8% of total assets. The company's liquidity FPT (…
Optomed's capital structure is characterized by a low debt-to-equity ratio of 0.11, indicating a conservative leverage profile, and a strong current ratio of 2.39, suggesting robust short-term liqu…
Organogenesis maintains a conservative capital structure with a debt-to-equity ratio of 0.05, indicating minimal leverage. The company's liquidity position is assessed as medium, with a current rat…
OSR Holdings Inc exhibits a highly leveraged capital structure with a debt-to-equity ratio of 0.06, indicating minimal reliance on debt financing. However, the company's liquidity position is weak,…
The company's capital structure is highly leveraged toward equity, with a negative total equity of -$5.02 million and a market cap of $79.03 million. Despite having $269,830 in cash and equivalents…
Prestige Consumer Healthcare Inc. manufactures and markets over-the-counter pharmaceutical and consumer health products, generating revenue through sales to retailers and distributors. The company…
Pacira Biosciences Inc has a market capitalization of $923.89 million and a price-to-earnings ratio of 131.35, indicating a high valuation relative to its earnings. The company's price-to-book rati…
Philips has a debt-to-equity ratio of 0.68, indicating a moderate reliance on debt financing, while its liquidity position is assessed as medium. The company reported negative operating cash flow o…
Pluri Inc operates with a highly leveraged capital structure, as evidenced by its total liabilities of $36.75 million, which significantly exceed its total assets of $36.39 million, resulting in a…
Insulet Corp maintains a strong liquidity position with $577.4 million in cash and equivalents, but its net cash is negative after subtracting total debt, indicating a potential liquidity risk. The…
Procept Biorobotics Corp maintains a strong liquidity position with $275.09 million in cash and equivalents, representing 54.1% of total assets, and a current ratio of 6.85, well above the industry…
ProQR Therapeutics maintains a market capitalization of $164.3 million and a price-to-book ratio of 3.33, indicating a premium valuation relative to its book value. The company's liquidity position…
Rigel Pharmaceuticals maintains a conservative capital structure with total equity of $391.5 million against total liabilities of $122.1 million. The debt-to-equity ratio stands at 0.13, indicating…
Rxsight operates with a highly liquid capital structure, evidenced by a current ratio of 10.95 and cash and equivalents of $19.95 million. The company's price-to-book ratio of 0.85 indicates a disc…
Sedana Medical has a market capitalization of 1,001.32 million SEK and a price-to-book ratio of 1.11, indicating a relatively modest premium over its book value. The company's liquidity position is…
Solar Foods Oyj has a liquidity position that is relatively strong, with a current ratio of 2.56, indicating that the company has more than twice the current assets to cover its current liabilities…
Sotera Health Co has a market capitalization of $4.48 billion and a price-to-earnings ratio of 57.47, indicating a high valuation relative to its earnings. The company's price-to-book ratio of 7.39…
Sonic Healthcare maintains a conservative capital structure with a debt-to-equity ratio of 0.62, indicating a balanced approach to financing. The company's liquidity position is characterized as me…
Silence Therapeutics maintains a strong liquidity position, with cash and equivalents amounting to $142.71 million, significantly exceeding its total liabilities of $88.96 million, resulting in a c…
Senti Biosciences operates with a market capitalization of $32.39 million and a price-to-book ratio of 0.73, indicating that the company is trading at a discount to its book value. The company's li…
Spruce Biosciences maintains a strong liquidity position, with $81.15 million in cash and equivalents, significantly exceeding its total liabilities of $20.92 million, resulting in a current ratio…
Sun Pharma Advanced Research Co Ltd exhibits a highly leveraged capital structure, with a debt-to-equity ratio of -1.24, indicating that the company's liabilities significantly exceed its equity. T…
STAAR Surgical Co has a market capitalization of $1.62 billion and a price-to-book ratio of 4.72, indicating a premium valuation relative to its book value. The company holds $153.15 million in cas…
Talphera operates with a strong liquidity position, as evidenced by its cash and equivalents of $12.12 million, which represents 42.1% of its total assets. The company has no long-term debt, and it…
Veeva Systems Inc maintains a strong liquidity position, with a current ratio of 4.29 and cash and equivalents of $1.2 billion, indicating a robust ability to meet short-term obligations. The compa…
Vijaya Diagnostic Centre Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.4, indicating a relatively low reliance on debt financing. The company's liquidity position…
Viemed Healthcare Inc maintains a market capitalization of $365.21 million and a price-to-earnings ratio of 24.45, indicating a moderate valuation relative to earnings. The company's price-to-book…
Yatharth Hospital & Trauma Care Services Ltd maintains a strong liquidity position, with a current ratio of 7.59, indicating a significant buffer of current assets over current liabilities. The com…
ZYUS.V operates with a negative equity position of CAD -5,344,000 and a debt-to-equity ratio of -2.28, indicating a highly leveraged capital structure. The company's liquidity is constrained, as ev…
The company maintains a strong liquidity position with a current ratio of 4.82, indicating a robust ability to meet short-term obligations. However, its net cash position is negative after subtract…
Haisco Pharmaceutical Group Co Ltd maintains a relatively strong liquidity position, with a current ratio of 1.81, indicating that it has sufficient current assets to cover its current liabilities.…
Daewon Pharmaceutical Co Ltd has a market price of 9,260 KRW and a market cap of 198.47 billion KRW, with a price-to-book ratio of 0.75 and a price-to-tangible-book ratio of 0.75. The company's liq…
Hanmi Science maintains a debt-to-equity ratio of 0.28, indicating a relatively conservative capital structure with limited leverage. The company's liquidity position is characterized as medium ris…
Dio Corp's capital structure is characterized by a debt-to-equity ratio of 0.42, indicating a relatively conservative leverage position compared to industry norms. The company holds 39.6 billion KR…
The company's capital structure is characterized by a debt-to-equity ratio of 1.05, indicating a moderate level of leverage. Its liquidity position is supported by cash and equivalents of 28,328,09…
JW Life Science Corp maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.3, indicating a low reliance on debt financing. The company's liquidity position is char…
The company's capital structure is highly leveraged, with a debt-to-equity ratio of 1.68, indicating a significant reliance on debt financing. Despite holding KRW 6.09 billion in cash and equivalen…
Dallah Healthcare maintains a debt-to-equity ratio of 0.96, indicating a balanced capital structure with moderate leverage. The company's liquidity position is characterized as medium, with a curre…
The company's capital structure is characterized by a debt-to-equity ratio of 0.5, indicating a relatively balanced mix of debt and equity financing. Its liquidity position is assessed as medium, w…
Zeria Pharmaceutical Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.47, indicating a balanced approach to financing. The company's liquidity position is characte…
Otsuka Holdings maintains a strong liquidity position, with cash and equivalents amounting to ¥485.89 billion, representing 13.3% of total assets. The company's liquidity FPT (free cash flow to tot…
The company maintains a strong liquidity position, with a current ratio of 83.35, indicating a significant excess of current assets over current liabilities. The absence of long-term debt and a deb…
The company maintains a strong liquidity position, with a current ratio of 52.91 and cash and equivalents amounting to ¥5,240,477,000, which significantly exceeds its total liabilities of ¥107,217,…
The company maintains a strong liquidity position, with a current ratio of 1.8, indicating sufficient short-term assets to cover its liabilities. However, its free cash flow of 79.82 million CNY is…
Asymchem Laboratories maintains a strong liquidity position, with a current ratio of 5.85 and cash and equivalents amounting to CNY 3.4 billion, which is significantly higher than the industry medi…
The company maintains a strong liquidity position, with a current ratio of 3.71, indicating a robust ability to meet short-term obligations. Its cash and equivalents amount to 54.2 billion JPY, whi…
ABDX.L's capital structure is characterized by a current ratio of 1.76, indicating a moderate level of liquidity, and a debt-to-equity ratio of 0.19, suggesting a relatively low reliance on debt fi…
Acarix AB maintains a strong liquidity position with a current ratio of 7.5 and holds SEK 63.9 million in cash and equivalents, representing 66.7% of total assets. The company is entirely equity-fu…
ALSMA.PA's capital structure shows a debt-to-equity ratio of 0.79, indicating a moderate level of leverage relative to its equity base. The company's liquidity position is characterized by a curren…
Alligator Bioscience AB has a negative net equity of -9.51 million SEK, indicating a significant deficit in its capital structure. The company's liquidity position is weak, with a current ratio of…
The company's capital structure shows a debt-to-equity ratio of 0.52, indicating a moderate level of leverage. Despite a negative return on equity of -2.49% and a return on assets of -1.44%, the co…
CNC.V's capital structure is characterized by a debt-to-equity ratio of 0.19, indicating a relatively low level of leverage. The company's liquidity position is weak, as evidenced by a current rati…
The company maintains a strong liquidity position, with a current ratio of 1.12 and $7.49 million in cash and equivalents, indicating sufficient short-term liquidity to cover its obligations. Its d…
Curis Inc has a market capitalization of $23.99 million and a price-to-book ratio of 4.39, indicating that the market is valuing the company at a premium to its book value. The company's liquidity…
DMYDB.ST has a highly liquid capital structure, with cash and equivalents amounting to 277.19 million SEK, significantly exceeding its total liabilities of 72.64 million SEK. The company's liquidit…
Vi sender deg én e-post når Handelsavisen lanseres. Ingen spam, ingen annen bruk.
Ved å registrere deg samtykker du til å motta ett enkelt varsel fra Handelsavisen på lanseringsdagen.